Etanercept shows promise for treating dermatomyositis

Links shared publicly online about this topic.

  • 213
    total visits

Etanercept shows promise for treating dermatomyositis

medicalxpress.com

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. These results are encouraging, but larger studies are needed to further investigate the safety and efficacy of ...

View full resource at medicalxpress.com

Tags: Rheumatoid Arthritis Medication, Drug, Enbrel, Safety

  • Share

Most Recently Shared on June 17, 2011 at 7:53 am By:

Etanercept shows promise for treating dermatomyositis

eurekalert.org — “A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. These results are encouraging, but larger studies are needed to further investigate the safety and efficacy of etanercept. Results of this clinical trial are available in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on June 17, 2011 at 4:35 am By:

eurekalert science news Health News

AAAS Etanercept shows promise for treating dermatomyositis http://bit.ly/lO4QAb

10 months ago...

Etanercept Shows Promise For Treating Dermatomyositis, Trial Found No Major Safety Concerns; Larger Studies Needed

medicalnewstoday.com — “A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. TheseView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 17, 2011 at 4:05 am By:

mnt_dermatology MNT Dermatology News Dermatology and Health News

Etanercept Shows Promise For Treating Dermatomyositis, Trial Found No Major Safety Concerns; Larger Studies Needed http://mnt.to/3XcT

10 months ago...

Advertisement